Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Hot Topics and Controversies in Atopic Dermatitis
Description
This session focuses on the hot topics and controversies surrounding atopic dermatitis, discussing various treatment options from an expert perspective. The speakers in attendance are well-versed in both clinical practice and research related to severe atopic dermatitis. The session will begin with a presentation on biologics, including their application and the appropriate circumstances for their use, delivered by Melinda Goodarum. Following her, Raj Chovatia, recently promoted to associate professor, will discuss JAK inhibitors and their role in treating severe eczema. Finally, Larry Akinfield will explore new topical treatments and strategies for integrating these medications into clinical practice, emphasizing shared decision-making with patients. Overall, the session aims to provide valuable insights for healthcare professionals dealing with atopic dermatitis.
Conclusions
- Atopic dermatitis treatment is evolving with the introduction of biologics and JAK inhibitors.
- Effective management of severe atopic dermatitis requires careful assessment of when to initiate, switch, or stop biologic therapy.
- New topical treatments are emerging that can complement existing therapies for atopic dermatitis.
- Shared decision-making with patients is critical when incorporating new treatments into clinical practice.
- Clinical studies and literature analyses play a vital role in understanding the most effective treatment strategies for severe atopic dermatitis.